OVID · Ovid Therapeutics Inc. · Executive Compensation
$2.44
+0.06 (+2.52%)
At close · Oct 5
Return incl. dividend (before tax)
Market Cap
$468.71M
Shares
195.30M
Volume · Oct 5
1.16M
Avg daily vol (3M)
1.63M
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2025
| Executive | Role | Total |
|---|---|---|
| Jeremy M. Levin | DPhil, MB BChir Executive Chairman and Former Chief Executive Officer | $1,934,699 |
| Margaret Alexander | President and Chief Executive Officer and Former Chief Operating Officer | $1,022,272 |
| Jeffrey Rona | Chief Business & Financial Officer | $969,164 |
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| Jeremy M. Levin | DPhil, MB BChir Chief Executive Officer | $2,774,102 |
| Margaret Alexander | President and Chief Operating Officer | $1,655,155 |
| Jeffrey Rona | Chief Business & Financial Officer | $1,518,796 |
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| Jeremy M. Levin | DPhil, MB BChir Chief Executive Officer | $2,107,495 |
| Thomas M. Perone | General Counsel & Corporate Secretary | $1,068,446 |
| Jeffrey Rona | Chief Business & Financial Officer | $1,061,098 |
Fiscal 2022
| Executive | Role | Total |
|---|---|---|
| Jeremy M. Levin | DPhil, MB BChir Chief Executive Officer | $3,127,762 |
| Jeffrey Rona | Chief Business & Financial Officer | $1,609,368 |
| Jason Tardio | Chief Operating Officer | $1,233,850 |
Fiscal 2021
| Executive | Role | Total |
|---|---|---|
| Jeffrey Rona | Chief Business & Financial Officer | $973,317 |
| Jeremy M. Levin | DPhil, MB BChir Chief Executive Officer | $847,069 |
| Thomas M. Perone | JD, MBA General Counsel & Corporate Secretary | $638,077 |
Fiscal 2020
| Executive | Role | Total |
|---|---|---|
| Jeremy M. Levin | DPhil, MB BChir. Chief Executive Officer | $2,135,499 |
| Jeffrey Rona | Chief Business & Financial Officer | $1,989,076 |
| Thomas M. Perone | JD, MBA General Counsel & Corporate Secretary | $1,475,516 |
Fiscal 2019
| Executive | Role | Total |
|---|---|---|
| Jeremy M. Levin | DPhil, MB BChir. Chief Executive Officer | $3,008,980 |
| Amit Rakhit | M.D., MBA President & CMO | $1,590,937 |
| Timothy Daly | EVP, Finance, Corporate Controller & Treasurer | $897,279 |
Fiscal 2018
| Executive | Role | Total |
|---|---|---|
| Amit Rakhit | M.D., MBA President & CMO | $1,548,112 |
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Charles Carter | Chief Financial Officer, principal financial officer, principal accounting officer and secretary | Appointed | 2026-07-08 |
| Anna Greka, M.D., Ph.D. | Class III director | Appointed | 2026-06-03 |
| Jeremy M. Levin | Executive Chairman | Appointed | 2025-11-12 |
| Margaret "Meg" Alexander | Class II member of the Company's Board of Directors | Appointed | 2025-11-12 |
| Margaret "Meg" Alexander | Chief Executive Officer | Appointed | 2025-11-12 |
| Stelios Papadopoulos, Ph.D. | Class I director | Appointed | 2025-03-05 |
| Margaret "Meg" Alexander | President and Chief Operating Officer | Appointed | 2024-09-11 |
| Jason Tardio | Chief Operating Officer | Terminated | 2024-06-28 |
| Thomas Perone | General Counsel, Chief Compliance Officer and Corporate Secretary | Terminated | 2024-06-28 |